AAN:Acorda’s Ampyra Runs Ahead of Other Multiple Sclerosis Treatments

From the article, "Ampyra is a new class of drug that isn’t made to slow the progression of MS like the other drugs on the market, but is meant to treat one of its most debilitating symptoms."